Join our daily newsletter At The Bell to receive exclusive market insights
- Hemp and medical cannabis company Cann Global (CGB) has appointed Marion Lesaffre as Chief Operating Officer (COO)
- Marion has been with the company for nearly ten years and had an instrumental role in the strategic direction of the business
- In her new role, she will be working alongside Managing Director, Sholom Feldman, and will review the operation processes to maximise growth
- Additionally, Cann Global has also appointed Franc Zvonar as Director of Sales and Marketing
- Frank joined the company in June and previously worked at Fiji Kava
- On the market today, Cann Global is in the grey and trading for 0.5 cents per share
Hemp and medical cannabis company Cann Global (CGB) has appointed Marion Lesaffre as Chief Operating Officer (COO).
Marion has been involved in the company for almost ten years. She had an instrumental role in the strategic direction of the business, this included the purchase of Medical Cannabis in 2017.
Amongst other projects, Marion was involved in the development of the food division, which initially launched the Vitahemp product range.
In her new role, she will be responsible for working with the company’s Managing Director Sholom Feldman in implementing the direction of Cann Global. Also as the COO she will review the operation processes to maximise growth.
“Marion has made a valuable contribution to the company for almost a decade and has more recently been responsible for our business operations and growth as Chief Operating Officer,” Sholom told the market.
“She has impressive operational expertise coupled with her passion for the success of the company, which we are confident will continue to propel the company to greater achievements and results,” he added.
Additionally, Cann Global has also appointed Franc Zvonar as Director of Sales and Marketing. Frank joined the company in June and previously worked at Fiji Kava.
“Both Marion and Franc bring a wealth of expertise and significant industry knowledge that will enhance our strategic plans to grow the company and to further accelerate our vision to capture a growing share of the burgeoning medicinal cannabis market,” Sholom said.
On the market today, Cann Global is in the grey and trading for 0.5 cents per share at 2:48 pm AEST.
